# Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis

> **NCT01524094** · PHASE3 · COMPLETED · sponsor: **Uppsala University** · enrollment: 49 (actual)

## Conditions studied

- Colorectal Peritoneal Carcinomatosis

## Interventions

- **DRUG:** Systemic chemotherapy alone (oxaliplatin, 5-fluorouracil, isovorin)
- **PROCEDURE:** Cytoreductive surgery (CRS) plus postoperative intraperitoneal chemotherapy (5-fluorouracil, isovorin)

## Key facts

- **NCT ID:** NCT01524094
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2010-12
- **Final completion:** 2012-01
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2012-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01524094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01524094, "Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01524094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*